Literature DB >> 234693

Effect of infusion of pharmacologic amounts of vasopressin on renal electrolyte excretion.

N A Kurtzman, P W Rogers, S Boonjarern, J A Arruda.   

Abstract

Aqueous vasopressin was infused to bicarbonate- and glucose-loaded dogs and to nonloaded antidiuretic dogs in doses of 50 mU/kg per min or 50 mU/kg per h. Both doses caused a marked increase in sodium, chloride, and water excretion. The larger dose raised the fractional excretion (sodium clearance (C-Na)/glomerular filtration rate (GFR) times 100) of these ions from 2% or less to in excess of 20%. Blocking the pressor effects of these doses of vasopressin with sodium nitroprusside did not alter the marked natriuretic and chloriuretic effect. The maximal rate of bicarbonate and glucose reabsorption was not depressed by vasopressin infusion; fractional phosphate excretion, however, was markedly increased. Inhibiting distal hydrogen ion secretion by inducing selective aldosterone deficiency failed to uncover a vasopressin-induced inhibition of proximal bicarbonate reabsorption that might have been masked by increased distal bicarbonate reabsorption. There was no significant change in GFR, renal plasma flow, or filtration fraction. The distribution of cortical renal blood flow (measured by the radioactive microsphere technique) shifted toward the inner cortex after vasopressin administration. Vasopressin, in pharmacologic doses, is a potent diuretic that most likely exerts this effect by directly inhibiting sodium reabsorption at a point in the nephron distal to the proximal tubule.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234693     DOI: 10.1152/ajplegacy.1975.228.3.890

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Dissociation between activation of the hypothalamo-hypophyseal antidiuretic system and the type of diuresis during acute intracranial hypertension. Experimental observation.

Authors:  Z M Rap; M Koca; G Hildebrandt; H W Mueller; H W Pia
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Vasopressin and anesthesia surgery.

Authors:  W H Wu; V K Zbuzek
Journal:  Bull N Y Acad Med       Date:  1982-06

Review 3.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

4.  Potassium in the syndrome of inappropriate antidiuretic hormone secretion.

Authors:  P L Padfield; J J Morton
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

5.  The effect of vasopressin on renal tubular 22Na efflux in the rat.

Authors:  G Fejes-Tóth; G Szénási
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

6.  Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range.

Authors:  R J Balment; M J Brimble; M L Forsling; C T Musabayane
Journal:  J Physiol       Date:  1984-07       Impact factor: 5.182

7.  Search for a natriuretic mechanism sensitive to sodium in the brain of the monkey.

Authors:  M A Kumar; S Swaminathan
Journal:  J Physiol       Date:  1977-11       Impact factor: 5.182

8.  Furosemide dynamics in conscious rabbits: modulation by arginine vasopressin.

Authors:  R Babini; P du Souich
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

9.  Effect of antidiuretic hormone and indomethacin on intrarenal microsphere distribution.

Authors:  G Fejes-Tóth; A Fekete; J Walter
Journal:  Pflugers Arch       Date:  1978-08-25       Impact factor: 3.657

10.  Effect of arginine vasopressin on renal medullary blood flow. A videomicroscopic study in the rat.

Authors:  B Zimmerhackl; C R Robertson; R L Jamison
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.